The possible repositioning of an oral anti-arthritic drug, auranofin, for Nrf2-activating therapy: The demonstration of Nrf2-dependent anti-oxidative action using a zebrafish model
Keywords: CDDO; 2-cyano-3,12-dioxooleana-1,9(11)-diene-28-oic acid; dpf; days post-fertilization; Keap1; Kelch-like ECH-associated protein 1; Nrf2; nuclear factor erythroid 2-related factor 2; Arsenite toxicity; Auranofin-induced protection; Heavy metal; Nrf2 pathw